Abstract
Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | 101-106 |
| Number of pages | 6 |
| Journal | Acta Clinica Croatica |
| Volume | 50 |
| Issue number | 1 |
| State | Published - Dec 1 2011 |
Fingerprint
Keywords
- Anticoagulants
- Platelet aggregation inhibitors
- Prevention and control
- Secondary prevention
- Stroke
- Therapeutic use
ASJC Scopus subject areas
- Medicine(all)
Cite this
Update on Antithrombotic Agents in Secondar y Stroke Prevention. / Rundek, Tatjana; Bašić-Kes, Vanja; Morović, Sandra; Demarin, Vida.
In: Acta Clinica Croatica, Vol. 50, No. 1, 01.12.2011, p. 101-106.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Update on Antithrombotic Agents in Secondar y Stroke Prevention
AU - Rundek, Tatjana
AU - Bašić-Kes, Vanja
AU - Morović, Sandra
AU - Demarin, Vida
PY - 2011/12/1
Y1 - 2011/12/1
N2 - Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.
AB - Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.
KW - Anticoagulants
KW - Platelet aggregation inhibitors
KW - Prevention and control
KW - Secondary prevention
KW - Stroke
KW - Therapeutic use
UR - http://www.scopus.com/inward/record.url?scp=84855161173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855161173&partnerID=8YFLogxK
M3 - Article
C2 - 22034789
AN - SCOPUS:84855161173
VL - 50
SP - 101
EP - 106
JO - Acta Clinica Croatica
JF - Acta Clinica Croatica
SN - 0353-9466
IS - 1
ER -